MedTrace Logo

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

NCT05006482 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 668

Last updated 2026-01-13

No results posted yet for this study

Summary

This phase III trial compares the effect of geriatric evaluation and management with survivorship health education (GEM-S) to usual care on patient-reported physical function in older survivors of cancer. Survivorship care for older adults of cancer usually consists of getting advice from their doctor. This advice may include how to do their daily activities, so they are less tired or how to manage multiple diseases, or long-term side effects from treatment. GEM-S may help improve the physical ability to perform activities of daily living, mental well-being, and memory in older survivors of cancer after chemotherapy. This study may help doctors learn if including GEM-S in their practices improves physical, mental and memory functions in their patients. The study may also help to understand how such care affects cancer patients and their caregivers' quality of life.

Conditions

Interventions

OTHER

Best Practice

Receive usual follow-up survivorship care

OTHER

Comprehensive Geriatric Assessment

Complete geriatric assessment

OTHER

Educational Intervention

Participate in survivorship health education sessions

OTHER

Exercise Intervention

Participate in SHE-EXCAP program

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Tailored Intervention

Participate in GEM consultation

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Rochester

    lead OTHER

Principal Investigators

  • Supriya G Mohile · University of Rochester NCORP Research Base

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-21
Primary Completion
2027-05-17
Completion
2027-09-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006482 on ClinicalTrials.gov